Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
Science Translational Medicine|December 8, 2017
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infectionMichael C Sneller, J Shawn Justement, Kathleen R Gittens, et al.
The New England Journal of Medicine|April 18, 2019
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment InterruptionChang-Yi Wang, Wing-Wai Wong, Hung-Chin Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccinationClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
Plos Pathogens|May 15, 2013
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patientSteven A Yukl, Eli Boritz, Michael Busch, et al.
AIDS (London, England)|June 15, 2021
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteriaJesse Fajnzylber, Radwa Sharaf, John N Hutchinson, et al.
Cell Host & Microbe|January 3, 2023
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapyXiaodong Lian, Kyra W Seiger, Elizabeth M Parsons, et al.
Science Translational Medicine|November 29, 2019
Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturationJames W Austin, Clarisa M Buckner, Lela Kardava, et al.
Pageof 25